{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:27:26Z","timestamp":1762504046080,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["62\/142,032","PCT\/US2016\/025607","WO2016\/161313A1"],"award-info":[{"award-number":["62\/142,032","PCT\/US2016\/025607","WO2016\/161313A1"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["tipsro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.tipsro.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T19:49:41Z","timestamp":1623440981000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Automatic localization of the prostatic urethra for image guided radiation therapy"],"prefix":"10.1016","volume":"19","author":[{"given":"Nicola J.","family":"Nasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-3572","authenticated-orcid":false,"given":"Jonathan","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyal","family":"Fenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed","family":"Agbarya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA: A Cancer Journal for Clinicians. 2021;71:7-33.","key":"10.1016\/j.tipsro.2021.05.002_b0005","DOI":"10.3322\/caac.21654"},{"key":"10.1016\/j.tipsro.2021.05.002_b0010","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.adro.2019.03.012","article-title":"Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data","volume":"4","author":"Weg","year":"2019","journal-title":"Advances in radiation oncology."},{"key":"10.1016\/j.tipsro.2021.05.002_b0015","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2 = 1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2021.05.002_b0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijrobp.2018.12.045","article-title":"Five-year outcomes of a phase 1 dose-escalation study using stereotactic body radiosurgery for patients with low-risk and intermediate-risk prostate cancer","volume":"104","author":"Zelefsky","year":"2019","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10.1016\/j.tipsro.2021.05.002_b0025","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies","volume":"104","author":"Jackson","year":"2019","journal-title":"International Journal of Radiation Oncology*Biology*Physics."},{"key":"10.1016\/j.tipsro.2021.05.002_b0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2018.02.029","article-title":"Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): a phase 2 randomized trial","volume":"127","author":"Quon","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.tipsro.2021.05.002_b0035","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.tipsro.2021.05.002_b0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2021.02.008","article-title":"Predictors for Post-treatment Biopsy Outcomes after Prostate Stereotactic Body Radiotherapy","volume":"159","author":"Zelefsky","year":"2021","journal-title":"Radiotherapy and oncology"},{"issue":"4","key":"10.1016\/j.tipsro.2021.05.002_b0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COC.0000000000000796","article-title":"Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes","volume":"44","author":"Paly","year":"2021","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.tipsro.2021.05.002_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijrobp.2020.09.054","article-title":"Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response","volume":"110","author":"Wang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6_suppl","key":"10.1016\/j.tipsro.2021.05.002_b0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1200\/JCO.2018.36.6_suppl.128","article-title":"Single-dose radiotherapy (SDRT) in the management of intermediate risk prostate cancer: Early results from a phase II randomized trial","author":"Greco","year":"2018","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.tipsro.2021.05.002_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tipsro.2021.01.002","article-title":"Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer","volume":"17","author":"Nasser","year":"2021","journal-title":"Technical Innovations & Patient Support in Radiation Oncology."},{"key":"10.1016\/j.tipsro.2021.05.002_b0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/acm2.12551","article-title":"Geometric and dosimetric impact of anatomical changes for MR-only radiation therapy for the prostate","volume":"20","author":"Nejad-Davarani","year":"2019","journal-title":"Journal of Applied Clinical Medical Physics."},{"unstructured":"Nasser NJ, Zelefsky MJ. Apparatus and method for visualization and automatic localization of hollow organ for image guided precision medicine. World Intellectual Property Organization; 2016. https:\/\/patentimages.storage.googleapis.com\/e1\/b5\/5e\/3bf5fce8c165df\/WO2016161313A1.pdf.","key":"10.1016\/j.tipsro.2021.05.002_b0070"},{"issue":"24","key":"10.1016\/j.tipsro.2021.05.002_b0075","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1212\/01.wnl.0000268580.86336.af","article-title":"Noninvasive imaging is improving but digital subtraction angiography remains the gold standard","volume":"68","author":"Hill","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.tipsro.2021.05.002_b0080","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1109\/TNS.1982.4336336","article-title":"Digital subtraction angiography","volume":"29","author":"Brody","year":"1982","journal-title":"IEEE Trans Nucl Sci"},{"key":"10.1016\/j.tipsro.2021.05.002_b0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1538574417698906","article-title":"CT angiography of peripheral arterial disease by 256-slice scanner: accuracy, advantages and disadvantages compared to digital subtraction angiography","volume":"51","author":"Mishra","year":"2017","journal-title":"Vascular and endovascular surgery."},{"key":"10.1016\/j.tipsro.2021.05.002_b0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1148\/radiol.2018172927","article-title":"Kinetic imaging in lower extremity arteriography: comparison to digital subtraction angiography","volume":"290","author":"Gy\u00e1n\u00f3","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.tipsro.2021.05.002_b0095","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.ijrobp.2004.01.041","article-title":"Correlating the degree of needle trauma during prostate brachytherapy and the development of acute urinary toxicity","volume":"59","author":"Eapen","year":"2004","journal-title":"International Journal of Radiation Oncology*Biology*Physics."},{"key":"10.1016\/j.tipsro.2021.05.002_b0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.brachy.2011.07.005","article-title":"American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy","volume":"11","author":"Davis","year":"2012","journal-title":"Brachytherapy."},{"key":"10.1016\/j.tipsro.2021.05.002_b0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.brachy.2016.02.003","article-title":"Long-term outcome of magnetic resonance spectroscopic image-directed dose escalation for prostate brachytherapy","volume":"15","author":"King","year":"2016","journal-title":"Brachytherapy."},{"key":"10.1016\/j.tipsro.2021.05.002_b0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.brachy.2014.08.044","article-title":"Dosimetric evaluation of clinical target volume in the postimplant analysis of low-dose-rate brachytherapy for prostate cancer","volume":"14","author":"Nasser","year":"2015","journal-title":"Brachytherapy."},{"key":"10.1016\/j.tipsro.2021.05.002_b0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.brachy.2014.01.007","article-title":"Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy","volume":"13","author":"Nasser","year":"2014","journal-title":"Brachytherapy."},{"key":"10.1016\/j.tipsro.2021.05.002_b0120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5114\/jcb.2015.52127","article-title":"Evaluation of the dosimetric impact of loss and displacement of seeds in prostate low-dose-rate brachytherapy","volume":"7","author":"Wang","year":"2015","journal-title":"Journal of contemporary brachytherapy."},{"key":"10.1016\/j.tipsro.2021.05.002_b0125","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/01.coc.0000091353.67232.e5","article-title":"Impact of Intraoperative Edema During Transperineal Permanent Prostate Brachytherapy on Computer-Optimized and Preimplant Planning Techniques","volume":"26","author":"Yamada","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.tipsro.2021.05.002_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2020.01.029","article-title":"Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study","volume":"146","author":"Greco","year":"2020","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.tipsro.2021.05.002_b0135","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamaoncol.2021.0039","article-title":"Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial","volume":"7","author":"Greco","year":"2021","journal-title":"JAMA oncology."},{"key":"10.1016\/j.tipsro.2021.05.002_b0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13014-015-0347-2","article-title":"Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?","volume":"10","author":"Loh","year":"2015","journal-title":"Radiation Oncology."},{"key":"10.1016\/j.tipsro.2021.05.002_b0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2010.03.017","article-title":"Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancer","volume":"96","author":"Delouya","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.tipsro.2021.05.002_b0150","article-title":"Optimal slice thickness for cone-beam CT with on-board imager","author":"Seet","year":"2010631","journal-title":"Biomed Imaging Interv J."},{"key":"10.1016\/j.tipsro.2021.05.002_b0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13014-019-1447-1","article-title":"Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging","volume":"14","author":"Osman","year":"2019","journal-title":"Radiation Oncology."},{"key":"10.1016\/j.tipsro.2021.05.002_b0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/acm2.12239","article-title":"Investigation of the radiation dose from cone-beam CT for image-guided radiotherapy: A comparison of methodologies","volume":"19","author":"Buckley","year":"2018","journal-title":"J Appl Clin Med Phys."},{"key":"10.1016\/j.tipsro.2021.05.002_b0165","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","article-title":"Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial","volume":"392","author":"Parker","year":"2018","journal-title":"The Lancet."},{"key":"10.1016\/j.tipsro.2021.05.002_b0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2019.03.002","article-title":"Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial","volume":"135","author":"Alayed","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.tipsro.2021.05.002_b0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.radonc.2009.11.003","article-title":"I-125 seed planning: An alternative method of urethra definition","volume":"94","author":"Anderson","year":"2010","journal-title":"Radiother Oncol"}],"container-title":["Technical Innovations & Patient Support in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632421000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632421000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:17:01Z","timestamp":1762503421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405632421000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":35,"alternative-id":["S2405632421000226"],"URL":"https:\/\/doi.org\/10.1016\/j.tipsro.2021.05.002","relation":{},"ISSN":["2405-6324"],"issn-type":[{"type":"print","value":"2405-6324"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automatic localization of the prostatic urethra for image guided radiation therapy","name":"articletitle","label":"Article Title"},{"value":"Technical Innovations & Patient Support in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tipsro.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}